The crisis, he says, is fueled by fentanyl, historical trauma, and a lack of resources. That’s why he and other Lummi leaders ...

Three Points Center, a residential treatment facility for adopted teens, has abruptly shut down on February 14, offering ...

An 8,000-square-foot building on Sweeter's Saco campus could be the treatment facility's new home for patients under 21.

TheraBionic is the only FDA-approved therapy indicated in liver cancer patients that fail first-line and second-line therapy, so that's really the place it takes right now in 2025. Patients can ...

Each of the RSU grants vests ratably in equal installments on the first, second, and third anniversaries of the grant date, subject to the recipient's continued service with the Company through the ...

A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

(MENAFN- EIN Presswire) Spravato® (esketamine) has been approved for use as a standalone treatment for depression, without the requirement of an accompanying antidepressant. Spravato, previously ...

“It’s so life-changing,” said Eldredge. Spravato is a ketamine-derived nasal spray that is FDA-approved for treatment-resistant depression. The Johnson & Johnson drug has been on the market ...

Harmony's Martinsburg clinic now offers SPRAVATO®, an FDA-approved nasal spray for treatment-resistant depression, providing fast-acting symptom relief. MARTINSBURG, WV, UNITED STATES ...

(NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced two ...

An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

Spravato (esketamine) was approved by the EMA in December as an adjunctive, add-on therapy for people with serious depression who don’t respond to treatment with at least two from the current ...